Pilot Projects Program
试点项目计划
基本信息
- 批准号:10281528
- 负责人:
- 金额:$ 38.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptedAffectAreaAwardCOVID-19 pandemicCenters of Research ExcellenceClinicalClinical ResearchClinical SciencesCollaborationsCommunicationCommunitiesCommunity OutreachConsultationsDataDevelopmentDiagnosisDisciplineDiseaseEnvironmentEvaluationEventEvolutionExtramural ActivitiesFacultyFosteringFundingGenerationsGoalsGrantHealthHealth PrioritiesHealth PromotionHealth StatusHealthcareHybridsInstitutionK-Series Research Career ProgramsLeadLettersMentorsNeeds AssessmentOnline SystemsPersonsPilot ProjectsPopulationPrevention approachProcessPublic HealthRequest for ApplicationsResearchResearch PersonnelResearch Project GrantsReview CommitteeRhode IslandServicesSurveysTalentsTranslational Researchbasecatalystcommunity based researchcommunity engaged researchcommunity engagementexperienceimprovedinnovationinter-institutionalinterdisciplinary collaborationmedically underservedpostersprogramssuccesssymposiumsynergismtranslational approachtranslational scientistvirtual
项目摘要
ABSTRACT – PILOT PROJECTS PROGRAM
While Advance CTR has served as a catalyst to transform the quality and quantity of clinical and translational
research (CTR) in Rhode Island, there remains a need to sustain these gains and evolve to address the
state’s health priorities with engagement of the community. Furthermore, we have identified new unmet
needs of investigators to foster interdisciplinary networks, to enhance community-based research efforts,
and to support awards for key preliminary data. This includes jump-start grants for junior investigators
applying for K awards. Therefore, in this renewal application, our goal is to expand the Pilot Project Program
and build on the transformative progress while evolving to meet the new needs of the investigator
community. The Specific Aims of the Pilot Projects Program (PPP) are to (1) award high-impact pilot
projects that propose to develop translational approaches for prevention, diagnosis, and treatment
of diseases and to improve health in RI; (2) facilitate clinical and translational research through
prioritization of interdisciplinary, inter-institutional, and community-based collaborations; (3)
promote professional development and extramural funding of junior faculty pilot project awardees
through synergy with Advance-CTR Core activities; and (4) strengthen collaboration and
communication among Rhode Island investigators through the Emerging Areas of Research
Symposium. In the PPP, we will continue to solicit, review, award, oversee, and evaluate one-year clinical
and translational science pilot projects from junior investigators and more senior investigators transitioning
to a CTR focus. Additional Micro-Grants will be made available to support generation of key preliminary
data. We will also promote interdisciplinary and inter-institutional networks of investigators by funding of
research retreats and small pilot grants to jump-start resulting new collaborations. We will prioritize clinical
and community engaged research and projects that address diseases that affect the medically underserved
and/or diseases that disproportionately affect RI population. The PPP will continue to leverage professional
development opportunities, functions, and facilities offered by other cores and services of Advance CTR. In
order to stimulate CTR and collaboration in high impact areas, the PPP will continue to host an annual
research symposium on relevant topics. The PPP will be led by Sharon Rounds (Core Lead) with co-Lead
Gaurav Choudhary. It will be supported by the PPP Steering/Review Committee that includes
representatives from all partner institutions plus community representatives. The PPP will continue to be an
integral part of the Advance CTR, catalyzing collaborative and community-based Clinical and Translational
Research to promote health.
Project Summary/Abstract Page 607
摘要 – 试点项目计划
虽然 Advance CTR 已成为改变临床和转化的质量和数量的催化剂
在罗德岛州的研究(CTR)中,仍然需要维持这些成果并不断发展以解决
此外,我们还发现了新的未满足的问题。
研究人员需要培育跨学科网络,加强基于社区的研究工作,
并支持对关键初步数据的奖励,其中包括为初级研究人员提供快速启动资助。
因此,在这次续签申请中,我们的目标是扩大试点项目计划。
并以变革性进展为基础,同时不断发展以满足研究者的新需求
试点项目计划 (PPP) 的具体目标是 (1) 奖励具有高影响力的试点项目。
提议开发预防、诊断和治疗转化方法的项目
疾病并改善 RI 的健康状况;(2) 通过以下方式促进临床和转化研究:
(3) 优先考虑跨学科、跨机构和社区合作;
促进初级教师试点项目获奖者的专业发展和校外资助
通过与 Advance-CTR 核心活动的协同作用;以及 (4) 加强合作;
罗德岛州研究人员通过新兴研究领域进行交流
在研讨会上,我们将继续征集、审查、奖励、监督和评估一年的临床。
初级研究人员和高级研究人员过渡的转化科学试点项目
将提供额外的小额赠款以支持关键初步的生成。
我们还将通过资助促进跨学科和跨机构的研究人员网络。
我们将优先考虑临床研究静修和小额试点资助,以启动新的合作。
和社区参与的研究和项目,解决影响医疗服务不足的人群的疾病
和/或对 RI 人口影响不成比例的疾病 PPP 将继续利用专业人士。
Advance CTR In 的其他核心和服务提供的开发机会、功能和设施。
为了刺激高影响领域的点击率和合作,PPP 将继续举办年度活动
相关主题的研究研讨会将由 Sharon Rounds(核心负责人)和共同负责人领导。
Gaurav Choudhary 将得到 PPP 指导/审查委员会的支持,其中包括
来自所有合作机构的代表以及社区代表将继续作为一个成员。
Advance CTR 的组成部分,促进协作和基于社区的临床和转化
研究促进健康。
项目摘要/摘要第 607 页
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sharon Irene Smith Rounds其他文献
Sharon Irene Smith Rounds的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sharon Irene Smith Rounds', 18)}}的其他基金
RI-Center for Clinical and Translational Science
RI-临床和转化科学中心
- 批准号:
10413517 - 财政年份:2021
- 资助金额:
$ 38.69万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10468390 - 财政年份:2021
- 资助金额:
$ 38.69万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10681738 - 财政年份:2021
- 资助金额:
$ 38.69万 - 项目类别:
RI-Center for Clinical and Translational Science
RI-临床和转化科学中心
- 批准号:
10403751 - 财政年份:2016
- 资助金额:
$ 38.69万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10595415 - 财政年份:2016
- 资助金额:
$ 38.69万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10281523 - 财政年份:2016
- 资助金额:
$ 38.69万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10466949 - 财政年份:2016
- 资助金额:
$ 38.69万 - 项目类别:
Advance Clinical and Translational Research (Advance-CTR)
高级临床和转化研究(Advance-CTR)
- 批准号:
10726129 - 财政年份:2016
- 资助金额:
$ 38.69万 - 项目类别:
相似国自然基金
WASP通过影响IL-6R内吞调控Tfh发育和功能
- 批准号:82302055
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
htsA蛋白通过影响碳水化合物摄取抵抗宿主免疫杀伤的机制研究
- 批准号:82302535
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
脱氧胆酸通过c-Abl-YAP通路调控肠粘膜屏障功能对肝脂肪变形成影响
- 批准号:82370558
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
四君子汤通过调节胃粘膜逆生细胞命运影响胃癌前疾病与胃癌发生的作用与机制研究
- 批准号:82373110
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
Piezo1通过PRMT1调节杯状细胞内质网稳态对IBS黏液屏障功能的影响与机制研究
- 批准号:82370548
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Implementation of Innovative Treatment for Moral Injury Syndrome: A Hybrid Type 2 Study
道德伤害综合症创新治疗的实施:2 型混合研究
- 批准号:
10752930 - 财政年份:2024
- 资助金额:
$ 38.69万 - 项目类别:
Regulation of human tendon development and regeneration
人体肌腱发育和再生的调节
- 批准号:
10681951 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
Implementation and Implications of Sickle Cell Trait Screening in the NCAA
镰状细胞性状筛查在 NCAA 中的实施及其意义
- 批准号:
10842764 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别:
Development of a novel visualization, labeling, communication and tracking engine for human anatomy.
开发一种新颖的人体解剖学可视化、标签、通信和跟踪引擎。
- 批准号:
10761060 - 财政年份:2023
- 资助金额:
$ 38.69万 - 项目类别: